JPMorgan Chase & Co. Purchases 6,476 Shares of Nutex Health Inc. $NUTX

JPMorgan Chase & Co. grew its position in Nutex Health Inc. (NASDAQ:NUTX) by 78.0% in the third quarter, Holdings Channel reports. The fund owned 14,782 shares of the company’s stock after acquiring an additional 6,476 shares during the quarter. JPMorgan Chase & Co.’s holdings in Nutex Health were worth $1,527,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of NUTX. State of Alaska Department of Revenue bought a new position in shares of Nutex Health in the 3rd quarter valued at $30,000. BNP Paribas Financial Markets lifted its stake in shares of Nutex Health by 966.7% in the 2nd quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock valued at $40,000 after acquiring an additional 290 shares during the last quarter. Bank of America Corp DE lifted its stake in shares of Nutex Health by 6,590.3% in the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock valued at $66,000 after acquiring an additional 2,043 shares during the last quarter. Vestcor Inc bought a new position in shares of Nutex Health in the 3rd quarter valued at $111,000. Finally, New York State Common Retirement Fund bought a new position in shares of Nutex Health in the 2nd quarter valued at $137,000. 5.32% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of brokerages have recently commented on NUTX. Weiss Ratings reiterated a “hold (c)” rating on shares of Nutex Health in a research note on Friday, March 27th. Wall Street Zen cut Nutex Health from a “strong-buy” rating to a “hold” rating in a research note on Saturday, March 7th. Two equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $252.50.

Nutex Health Stock Up 2.1%

Shares of NASDAQ:NUTX opened at $105.04 on Thursday. The firm has a market cap of $732.13 million, a P/E ratio of 11.70 and a beta of 0.10. The company has a quick ratio of 3.39, a current ratio of 3.41 and a debt-to-equity ratio of 0.70. Nutex Health Inc. has a 12-month low of $77.21 and a 12-month high of $193.07. The business has a fifty day simple moving average of $104.75 and a 200 day simple moving average of $125.84.

Nutex Health (NASDAQ:NUTX) last announced its earnings results on Thursday, March 5th. The company reported $1.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.56 by ($3.95). The company had revenue of $151.68 million for the quarter, compared to the consensus estimate of $258.82 million. Nutex Health had a return on equity of 17.67% and a net margin of 7.34%.

About Nutex Health

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.